Formoterol Fumarate
Product Images NDC 0904-7454

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Formoterol Fumarate (NDC 0904-7454). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (0151e3b9 8d37 4bf5 A675 F2328907e181 01)

Chemical structure of formoterol fumarate dihydrate showing the molecular arrangement of formoterol and fumaric acid with associated water molecules.*

FDA Label Image

Perforomist Figure 1 (0151e3b9 8d37 4bf5 A675 F2328907e181 02)

A line chart comparing mean FEV1 (in liters) over 12 hours between Formoterol Fumarate Inhalation Solution 20 mcg (N=123) and placebo (N=114). The chart shows hours on the x-axis and mean FEV1 in liters on the y-axis, illustrating higher FEV1 values for Formoterol Fumarate treatment compared to placebo across the time period.*

FDA Label Image

Perforomist Figure 2 (0151e3b9 8d37 4bf5 A675 F2328907e181 03)

A line graph comparing mean FEV1 (liters) over 12 hours between Formoterol Fumarate Inhalation Solution 20 mcg and placebo. The y-axis represents mean FEV1 in liters, and the x-axis represents time in hours. Formoterol shows consistently higher mean FEV1 values than placebo throughout the time period.*

FDA Label Image

Figure 1 (0151e3b9 8d37 4bf5 A675 F2328907e181 04)

An instructional illustration showing hands assembling or preparing a drug delivery device, specifically inserting or attaching a component onto an inhaler or similar apparatus. The diagram is labeled with the number 1, indicating it is part of a step-by-step process for use or assembly.*

FDA Label Image

Figure 2 (0151e3b9 8d37 4bf5 A675 F2328907e181 05)

An instructional diagram showing a close-up of an inhaler device and a hand holding it, illustrating how to use or assemble the inhaler. The image is labeled with the number 2 in the bottom right corner, likely indicating a step in a usage or assembly guide for Formoterol fumarate inhalation aerosol.*

FDA Label Image

Figures 3 And 4 (0151e3b9 8d37 4bf5 A675 F2328907e181 06)

Two-step instructional illustration showing a person using a Formoterol fumarate inhaler. The first image depicts the user placing the mouthpiece of the inhaler into their mouth and preparing to inhale. The second image shows the user holding the inhaler with a face mask properly covering the nose and mouth for medication delivery.*

FDA Label Image

1s Pouch (0151e3b9 8d37 4bf5 A675 F2328907e181 07)

The packaging label for Formoterol Fumarate Inhalation Solution by Major Pharmaceuticals features a 20 mcg/2 mL sterile unit-dose vial. It specifies usage for oral inhalation only, is marked Rx Only, and includes the NDC 0904-7454-98. The label contains storage and handling instructions, manufacturer and distributor information, and a barcode.*

FDA Label Image

20 Mcg/2 mL-30s Carton (0151e3b9 8d37 4bf5 A675 F2328907e181 08)

Box label for Formoterol fumarate inhalation solution 20 mcg/2 mL vial by Major Pharmaceuticals. The carton contains thirty sterile unit dose vials, individually wrapped for oral inhalation only. The label includes storage instructions, active and inactive ingredients, and distributor information for Major Pharmaceuticals in Indianapolis, USA.*

FDA Label Image

4s Pouch (0151e3b9 8d37 4bf5 A675 F2328907e181 09)

Formoterol Fumarate Inhalation Solution 20 mcg/2 mL vial by Major Pharmaceuticals. The label indicates it is a sterile unit-dose vial for oral inhalation only, with four 2 mL sterile unit-dose vials per package. Distributed by Major Pharmaceuticals, Indiana, USA, and marked for Rx only.*

FDA Label Image

20 Mcg/2 mL-60s Carton (0151e3b9 8d37 4bf5 A675 F2328907e181 10)

Formoterol Fumarate 20 mcg/2 mL vial inhalation solution packaging label by Major Pharmaceuticals. The label states the product is a sterile unit dose for oral inhalation, with each 2 mL vial containing 20 mcg of active formoterol fumarate. Carton contains 60 vials. Storage instructions and patient information are included, and the product is distributed by Major Pharmaceuticals, Indianapolis, IN.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.